Success in treating rheumatoid arthritis

Israel’s Can-Fite BioPharma has announced positive results in its Phase IIb trial of their CF101 treatment for patients with active rheumatoid arthritis.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000903835&fid=1725

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *